Systemic treatment for unresectable hepatocellular carcinoma

doi:10.3748/wjg.v29.i10.1551

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6299)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

318

WORD

HTML

3726

Figures (1-2)

445

Tables (1-2)

358

Sum=4882

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

141

Download

440

Sum=581

Publishing Process of This Article

Item

Count

Browse

215

Download

621

Sum=836

Mar 14, 2023 (publication date) through Dec 30, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Mar 14, 2023; 29(10): 1551-1568
Published online Mar 14, 2023. doi: 10.3748/wjg.v29.i10.1551

Open in New Tab Full Size Figure Download Figure

Figure 1 First-line systemic therapy in unresectable hepatocellular carcinoma. ECOG PS: Eastern Cooperative Oncology Group Performance Status; ICIs: Immune checkpoint inhibitors; HCC: Hepatocellular carcinoma.

Open in New Tab Full Size Figure Download Figure

Figure 2 Second-line systemic therapy in unresectable hepatocellular carcinoma. DP: Disease progress; ECOG PS: Eastern Cooperative Oncology Group Performance Status; ICIs: Immune checkpoint inhibitors; HCC: Hepatocellular carcinoma; AFP: Alpha-fetoprotein.

Citation: Leowattana W, Leowattana T, Leowattana P. Systemic treatment for unresectable hepatocellular carcinoma. World J Gastroenterol 2023; 29(10): 1551-1568
URL: https://www.wjgnet.com/1007-9327/full/v29/i10/1551.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i10.1551